No evidence for a clear link between active intestinal inflammation and autism based on analyses of faecal

Elisabeth Fernell1, Ulrika L Fagerberg, Per M Hellström

  • 1Department of Neuropaediatrics, Astrid Lindgren Children's Hospital, Karolinska Institutet, Karolinska University Hospital Solna, 171 76 Stockholm, Sweden. elisabeth.fernell@karolinska.se

Insights

This study investigated intestinal inflammation in children with autism using two markers. Results showed no evidence linking autism to active gut inflammation in most children.

Area of Science:

  • Pediatric Gastroenterology
  • Neurodevelopmental Disorders
  • Immunology

Background:

  • Parental concerns exist regarding bowel habits in children with autism.
  • The potential association between autism spectrum disorder (ASD) and intestinal inflammation is under investigation.
  • Inflammatory markers may offer insights into gastrointestinal issues in ASD.

Purpose of the Study:

  • To analyze two key inflammatory markers in children diagnosed with autism.
  • To explore a potential link between autism and active intestinal inflammation.
  • To address parental concerns about bowel irregularities in autistic children.

Main Methods:

  • Investigated 24 children with autism (ages 3-13) of unknown etiology.
  • Measured fecal calprotectin and rectal nitric oxide (NO) levels.
  • Utilized two independent markers to assess gut inflammatory reactions.

Main Results:

  • One child with a history of severe Clostridium difficile infection showed elevated markers.
  • Another child with severe constipation had elevated fecal calprotectin.
  • The majority of children exhibited results not indicative of active intestinal inflammation.

Conclusions:

  • No evidence was found to support a link between autism and active intestinal inflammation.
  • Rectal nitric oxide (NO) and fecal calprotectin did not indicate a connection in this cohort.
  • Further research may be needed to fully understand gut-brain axis interactions in autism.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...